Tilray Brands, Inc. (TLRY)
About Tilray Brands, Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $821.3M
- Net income
- -$2.2B
- Total assets
- $2.1B
- Market cap
- $479.0M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $479.0M
- Shares outstanding
- 170.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 23, 2015
Tilray Brands, Inc. (TLRY) Stock Price
- Reported a net loss of $2.2B in FY2025.
- Trading 87% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Tilray Brands, Inc..
Write a review
News about Tilray Brands, Inc.
News & sentiment via Polygon.io
Tilray Brands, Inc.: frequently asked questions
Is Tilray Brands, Inc. an American company?
Tilray Brands, Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Tilray Brands, Inc. headquartered?
Tilray Brands, Inc. is headquartered in New York, New York, United States.
Is Tilray Brands, Inc. publicly traded?
Yes — Tilray Brands, Inc. is a publicly traded company. Its stock trades under the ticker symbol TLRY on the NASDAQ.
What does Tilray Brands, Inc. do?
Tilray Brands, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
